Received 25 April 2001/
Returned for modification 4 June 2001/
Accepted 12 November 2001
| 1. |
Arnoldi, J., and H. Moll. 1998. Langerhans cell migration in murine cutaneous leishmaniasis: regulation by tumour necrosis factor alpha, interleukin-1 beta, and macrophage inflammatory protein-1 alpha. Dev. Immunol. 6:3-11.[Medline] |
| 2. |
Barratt-Boyes, S. M., M. I. Zimmer, L. A. Harshyne, E. M. Meyer, S. C. Watkins, S. Capuano, M. Murphey-Corb, L. D. Falo, and A. D. Donnenberg. 2000. Maturation and trafficking of monocyte-derived dendritic cells in monkeys: implications for dendritic cell-based vaccines. J. Immunol. 164:2487-2495.[Abstract/Free Full Text] |
| 3. |
Flohe, S. B., C. Bauer, S. Flohe, and H. Moll. 1998. Antigen-pulsed epidermal Langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major. Eur. J. Immunol. 28:3800-3811.[CrossRef][Medline] |
| 4. |
Frankenburg, S., A. Gross, and V. Leibovici. 1992. Leishmania major and Leishmania donovani: effect of LPG-containing and LPG-deficient strains on monocyte chemotaxis and chemiluminescence. Exp. Parasitol. 75:442-448.[CrossRef][Medline] |
| 5. |
Guler, M. L., N. G. Jacobson, U. Gubler, and K. M. Murphy. 1997. T cell genetic background determines maintenance of IL-12 signaling-effects on BALB/c and B10.D2 T helper cell type 1 phenotype development. J. Immunol. 159:1767-1774.[Abstract] |
| 6. |
Jebbari, H., and R. N. Davidson. 1998. Recent advances in leishmaniasis. Curr. Opin. Infect. Dis. 11:535-539. |
| 7. |
Knight, S. C., and A. J. Stagg. 1993. Antigen-presenting cell types. Curr. Opin. Immunol. 5:374-382.[CrossRef][Medline] |
| 8. |
Konecny, P., A. J. Stagg, H. Jebbari, N. English, R. N. Davidson, and S. C. Knight. 1999. Murine dendritic cells internalise Leishmania major promastigotes, produce IL-12 and stimulate primary T cell proliferation in vitro. Eur. J. Immunol. 29:1803-1811.[CrossRef][Medline] |
| 9. |
Kremer, I., M. P. Gould, K. D. Cooper, and F. P. Heinzel. 2001. Pre-treatment with recombinant Flt3 ligand partially protects against cutaneous leishmaniasis in susceptible BALB/c mice. Infect. Immun. 69:673-680.[Abstract/Free Full Text] |
| 10. |
Maestroni, G. J. 2000. Dendritic cell migration controlled by alpha 1b-adrenergic receptors. J. Immunol. 165:6743-6747.[Abstract/Free Full Text] |
| 11. |
Moll, H., H. Fuchs, C. Blank, and M. Rollinhoff. 1993. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells. Eur. J. Immunol. 23:1595-1601.[Medline] |
| 12. |
Moll, H., S. Flohe, and M. Rollinghoff. 1995. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen- specific T-cell immune response. Eur. J. Immunol. 25:693-699.[Medline] |
| 13. |
Moll, H. 1997. The role of chemokines and accessory cells in the immunoregulation of cutaneous leishmaniasis. Berhing Inst. Mitt. Mar:73-78. |
| 14. |
Moody, S. F., E. Handman, and A. Bacic. 1991. Structure and antigenicity of the lipophosphoglycan of Leishmania major amastigotes. Glycobiol. 1:419-424.[Abstract/Free Full Text] |
| 15. |
Moody, S. F., E. Handman, M. J. McConville, and A. Bacic. 1993. The structure of Leishmania major amastigote lipophosphoglycan. J. Biol. Chem. 268:18457-18466.[Abstract/Free Full Text] |
| 16. |
Panaro, M. A., M. Panunzio, E. Jirillo, A. Marangi, and O. Brandonisio. 1995. Parasite escape mechanisms: the role of Leishmania lipophosphoglycan on human phagocyte functions. A review. Immunopharmacol. Immunotoxicol. 17:595-605. |
| 17. |
Panaro, M. A., V. Puccini, S. M., Faliero, R. Marzio, A. Marangi, S. Lisi, and O. Brandonisio. 1996. Leishmania donovani lipophosphoglycan (LPG) inhibits respiratory burst and chemotaxis of dog phagocytes. Microbiologica 19:107-112.[Medline] |
| 18. |
Price, A. A., M. Cumberbatch, I. Kimber, and A. Ager. 1997. Alpha 6 integrins are required for Langerhans cell migration from the epidermis. J. Exp. Med. 186:1725-1735.[Abstract/Free Full Text] |
| 19. |
Richters, C. D., E. A. Reits, A. M. Van Pelt, M. J. Hoekstra, J. Van Baare, J. S. Du Pont, and E. W. Kamperdijk. 1996. Effect of low dose UVB irradiation on the migratory properties and functional capacities of human skin dendritic cells. Clin. Exp. Immunol. 104:191-197.[CrossRef][Medline] |
| 20. |
Roberts, G. M., and I. Laffafian. 1996. Human cord blood-derived large myeloid cells: spontaneous shape change and chemotactic movement. Br. J. Biomed. Sci. 53:96-100.[Medline] |
| 21. |
Sato, N., S. K. Ahuja, M. Quinones, V. Kostecki, R. L. Reddick, P. C. Melby, W. A. Kuziel, and S. S. Ahuja. 2000. CC chemokine receptor (CCR)2 is required for Langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells: absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, B cell outgrowth, and sustained neutrophilic inflammation. J. Exp. Med. 192:205-218. |
| 22. |
Von Stebut, E., Y. Belkaid, T. Jakob, D. L. Sacks, and M. C. Udey. 1998. Uptake of Leishmania major amastigotes results in activation and Interleukin-12 release from skin derived dendritic cells: implications for initiation of anti-Leishmania immunity. J. Exp. Med. 188:1547-1552.[Abstract/Free Full Text] |